Font Size: a A A

Study The Clinical Efficacy Evaluation Of Chronic Heart Failure From The "Triple Burner Theory"

Posted on:2020-09-27Degree:MasterType:Thesis
Country:ChinaCandidate:J WangFull Text:PDF
GTID:2434330599976934Subject:Integrative Medicine
Abstract/Summary:PDF Full Text Request
Purpose:The purpose of this study was to treat the patients with CHF in patients with CHF by applying Shuli Sanjiao Decoction.To observe the effect of the drug on the clinical efficacy of CHF patients,analyze and compare the changes of various indicators,and verify the "Sparse Trifocal Method".To treat the clinical efficacy of CHF,to clarify the relationship between "trifocal theory" and the essence of CHF Chinese medicine,and provide a theoretical basis for the clinical application of traditional Chinese medicine in the treatment of CHF.Material and method:The subjects of this study were patients who were admitted to the cardiopulmonary K outpatient of the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from January 2018 to December 2018.A total of 70 patients with chronic HF-REF(heart function II,III)with qi deficiency,blood stasis and coronary heart disease were included in the study,Randomly divided into the experimental group(Slimming Sanjiao Chinese Medicine Decoction + Basic Western Medicine)and the control group(basic Western medicine treatment),35 cases in each group,the course of treatment was 4 weeks.The changes of TCM syndrome scores,cardiac function classification,6-minute walk test,heart failure quality of life score,NT-proBNP content and systolic function index(EF value)were observed before and after the two groups of subjects.The basic vital signs and safety indicators during the study period of the two groups were observed and recorded.Results:1.Normal information:Before treatment,there was no significant difference in gender,age,disease duration and underlying disease distribution between the two groups(P>0.05).2.TCM syndrome scores: Before treatment,the TCM syndrome scores of the two groups were compared,P=0.640,no statistical difference.After treatment,the scores of TCM syndromes in the experimental group were lower than those in the control group,P<0.01,and there were significant differences.In the improvement analysis of TCM syndrome scores after treatment,the total effective rate of the experimental group(93.93%)was higher than that of the control group(84.85%),and there was a significant difference between the groups(P<0.01).Before treatment,the scores of TCM symptom scores in both groups were P>0.05,no statisticaldifference;after treatment,the single score of TCM symptoms in the test group was lower than that in the control group,P<0.05,there were significant differences.3.Cardiac function classification:Before treatment,the two groups of cardiac function were compared,P=0.804,no statistical difference.After treatment,the total effective rate of the experimental group(96.97%)was higher than that of the control group(81.82%),comparison between groups,P=0.029,there were significant differences.4.Heart failure quality of life score:Before treatment,the quality of life scores of the two groups were compared,P=0.630,no statistical difference.After treatment,the quality of life score of the test group was lower than that of the control group,P=0.002,there was significant difference.5.6-minute walk test:Before treatment,the two groups of 6-minute walking test were compared,P=0.616,no statistical difference.After treatment,the test group 6-minute walking distance was higher than the control group,P<0.01,there was significant difference.6.NT-proBNP levels:Before treatment,the levels of NT-proBNP in the two groups were compared,P=0.351,no statistical difference.After treatment,the level of NT-ProBNP in the experimental group was lower than that in the control group,P<0.01,there was a significant difference.7.Cardiac systolic function index(EF value):Before treatment,the EF values of the two groups were compared,P=0.495,no statistical difference.After treatment,the EF value of the test group was higher than that of the control group,P<0.01,there was significant difference.Conclusion:1.Shuli Sanjiao Chinese Medicine Decoction combined with Western medicine basic treatment is more effective than basic Western medicine treatment of CHF.2.Shuli Sanjiao Chinese Medicine Decoction can significantly improve the clinical symptoms and signs of patients with qi deficiency and blood stasis and stop CHF,improve their exercise tolerance,improve their systolic function and quality of life.It is confirmed that the "trifocal theory" is consistent with the essence of CHF's qi deficiency and blood stasis.3.Shuli Sanjiao Chinese Medicine Decoction has no adverse reactions and side effects,is safe and effective,and is worthy of clinical application.
Keywords/Search Tags:Chronic heart failure, Trifocal theory, Clinical efficacy
PDF Full Text Request
Related items